Transforming growth factor-β1 in hypertensive renal injury in Dahl salt-sensitive rats

Journal of the American Society of Nephrology

Volumn 7, Issue 12, 1996, Pages 2578-2589

  Tamaki, Kiyoshi ^a   Okuda, Seiya ^a   Nakayama, Masaru ^a   Yanagida, Taihei ^a   Fujishima, Masatoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Arteriosclerosis; Dahl salt sensitive rats; Glomerulosclerosis; Hypertension; Transforming growth factor

Indexed keywords

BINDING PROTEIN; CARRIER PROTEIN; COLLAGEN TYPE 1; FIBRONECTIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOSCLEROSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GLOMERULOSCLEROSIS; HYPERTENSION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SALT INTAKE;

EID: 0030405164     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Tracy RE, Duran MV, Heigle T, Oalmann MC: Two variants of nephrosclerosis separately related to age and blood pressure. Am J Pathol 1988;131:270-282.
2. Kashgarian M. Hypertensive disease and kidney structure. In: Laragh JH, Brenner BM, Eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York: Raven Press; 1990:389-398.
3. Hill GS, Heptinstall RH: Steroid-induced hypertension in the rat. Am J Pathol 1968;52:1-9.
4. Brenner BM: Nephron adaptation to renal injury or ablation. Am J Physiol 1985;249:F324-F337.
5. Rennke HG: Structural alterations associated with glomerular hyperfiltration. Contemp Issues Nephrol 1986: 14:111-131.
6. Chobanian AV: The influence of hypertension and other hemodynamic factors in atherogenesis. Prog Cardiovasc Dis 1983;26:177-196.
7. Bruijn JA, Hogendoorn PCW, Hodeedemaeker PJ, Fleuren GJ: The extracellular matrix in pathology. J Lab Clin Med 1988;111:140-149.
8. Klahr S, Schreiner G, Ichikawa I: The progression of renal disease. N Engl J Med 1988;318:1657-1666.
9. Kuscio GS, Neilson EG, Haverty T: Mechanism of tubulointerstitial fibrosis. Kidney Int 1991;39:550-556.
10. Roberts AB, Sporn MB, Assoian RK, et al.: Transforming growth factor-β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167-4171.
11. Lawrence WT, Sporn MB, Gorschboth C, Norton JA, Grotendorst GR: The reversal of an adriamycin induced healing impairment with chemoattractants and growth factors. Ann Surg 1986;203:142-147.
12. Morales TI, Roberts AB: Transforming growth factor β regulates the metabolism of proteoglycans in bovine cartilage organ culture. J Biol Chem 1988;263:12828-12831.
13. Okuda S, Languino LR, Ruoslahti E, Border WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephrltis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 1990;86:453-462.
14. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature (Lond) 1990;346:371-373.
15. Tamaki K, Okuda S, Ando T, Iwamoto T, Nakayama M, Fujishima M: TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int 1994; 45:525-536.
16. Rapp JP, Dene H: Development and characteristics of inbred strains of Dahl salt-sensitive rats. Hypertension 1985;7:340-349.
17. Sterzel RB, Luft FC, Gao Y, et al.: Renal disease and the development of hypertension in salt-sensitive Dahl rats. Kidney Int 1988;33:1119-1129.
18. Raij L, Azar S, Keane W: Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 1984;26:137-143.
19. Bennett WM, Walker RG, Kincaid-Smith P: Renal cortical interstitial volume in mesangial IgA nephropathy. Lab Invest 1982;47:330-335.
20. Bader R, Bader H, Grund KE, Mackensen-Haen S, Christ H, Bohle A: Structure and function of the kidney in diabetic glomerulosclerosis: correlations between morphological and functional parameters. Pathol Res Pract 1980;167:204-216.
21. Kanzaki T, Olofsson A, Moren A, et al.: TGF-β1 binding protein: A component of the large latent complex of TGF-β1 with multiple repeat sequences. Cell 1990;61: 1051-1061.
22. Miyazono K, Olofsson A, Colosetti P, Heldin CH: A role of the latent TGF-β1 binding protein in the assembly and secretion of TGF-β1. EMBO J 1991;10:1091-1101.
23. Olofsson A, Miyazono K, Kanzaki T, Colosetti P, Engstrom U, Heldin CH: Transforming growth factor-β 1, -β 2, and -β 3 secreted by a human gliobiastoma cell line. Identification of small and different forms of large latent complexes. J Biol Chem 1992;267:19482-19488.
24. Waltenberger J, Lundin L, Oberg K, et al.: Involvement of transforming growth factor-β in the formation of fibrotic lesions in carcinoid heart disease. Am J Pathol 1993;142:71-78.
25. Taketazu F, Kato M, Gobl A, et al.: Enhanced expression of transforming growth factor-βs and transforming growth factor-β type II receptor in the synovial tissues of patients with rheumatoid arthritis. Lab Invest 1994;70: 620-630.
26. Waltenberger J, Wanders A, Fellstrom B, Miyazono K, Heldin CH, Funa K: Induction of transforming growth factor-β during cardiac allograft rejection. J Immunol 1993;151:1147-1157.
27. Striker GE, Striker LJ: Biology of disease. Glomerular cell culture. Lab Invest 1985;53:123-128.
28. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 1970;227:680-685.
29. Border WA, Okuda S, Languino LR, Ruoslahti E: Transforming growth factor-β regulates production of proteoglycan by mesangial cells. Kidney Int 1990;37:689-695.
30. Tomooka S, Border WA, Marshall BC, Noble NA: Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int 1992;42:1462-1469.
31. Danielpour D, Dart LL, Flanders KC, Roberts AB, Sporn MB: Immunodetection and quantitation of two forms of transforming growth factor-β (TGF-β1 and β2) secreted by cells in culture. J Cell Physiol 1989;138:79-88.
32. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biological active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18:5294-5299.
33. Tsuji T, Okada F, Yamaguchi K, Nakamura T: Molecular cloning of the large subunit of transforming growth factor type β masking protein and expression of the mRNA in various rat tissues. Proc Natl Acad Sci USA 1990;87:8835-8839.
34. Franzen P, ten Dijke P, Ichjo H, et al.: Cloning of TGF-β type I receptor that forms a heterometric complex with the TGF-β type II receptor. Cell 1993;75:681-692.
35. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF: Expression cloning of the TGF-β type II receptor. A functional transmembrane serine/threonine kinase. Cell 1992;68:775-785.
36. Wang XF, Lin HY, Ng-Eaton E, Downward J, Lodish HF, Weinberg RA: Expression cloning and characterization of the TGF-β type III receptor. Cell 1991;67:797-805.
37. Schwartzbauer JE, Tamkun JW, Lemischka IR, Hynes RO: Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell 1983;35:421-431.
38. Liau G, Yamada Y, de Crombrugghe B: Coordinate regulation of the levels of type III and type I collagen mRNA in most but not all mouse fibroblasts. J Biol Chem 1985;260:531-536.
39. Zeheb R, Gelehrter TD: Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1. Gene 1988; 73:459-468.
40. Coimbra T, Wiggins R, Noh JW, Merritt S, Phan SH: Transforming growth factor-β production in antiglomerular basement membrane disease in the rabbit. Am J Pathol 1991;138:223-234.
41. Miyazono K, Hellmann U, Wernstedt C, Heldin CH: Latent high molecular weight complex of transforming growth factor-β1. Purification from human platelets and structural characterization. J Biol Chem 1988;263: 6407-6415.
42. Okada F, Yamaguchi K, Ichihara A, Nakamura T: Purification and structural analysis of a latent form of transforming growth factor-β from rat platelets. J Biochem 1989;106:304-310.
43. Tamaki K, Okuda S, Miyazono K, Nakayama M, Fujishima M: Matrix-associated latent TGF-β with latent TGF-β binding protein in the progressive process in adriamycin-induced nephropathy. Lab Invest 1995;73: 81.
44. Mizoi T, Ohtani H, Miyazono K, Miyazawa M, Matsuno S, Nagura H: Immunoelectron microscopic localization of transforming growth factor-β1 and latent transforming growth factor-β1 binding protein in human gastrointestinal carcinomas: Qualitative difference between cancer cells and stromal cells. Cancer Res 1993;53:183-190.
45. Vaheri A, Salonen EM, Varito T: Fibronectin in formation and degradation of the pericellular matrix. CIBA Found Symp 1985;114:111-126.
46. Edwards DR, Murphy G, Reynolds JJ, et al.: Transforming growth factor-β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987;6: 1899-1904.
47. Laiho M, Saksela O, Keski-Oja J: Transforming growth factor-β induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. J Biol Chem 1987;262:17467-17474.
48. Ignotz RA, Massague J: Cell adhesion protein receptors as targets for transforming growth factor-β action. Cell 1987;51:189-197.
49. Sporn MB, Roberts AB, Wakefield LM de Crombrugghe B: Some recent advances in the chemistry and biology of transforming growth factor-β. J Cell Biol 1987;105: 1039-1045.
50. Chen JK, Hoshi H, McKeehan WL: Transforming growth factor-β specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. Proc Natl Acad Sci USA 1987;84:5287-5291.
51. Eklov S, Funa K, Nordgren H, et al.: Lack of the latent transforming growth factor β binding protein in malignant, but not benign prostatic tissue. Cancer Res 1993; 53:3193-3197.
52. Taipale J, Miyazono K, Heldin CH, Keski-Oja J: Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J Cell Biol 1994;124:171-181.
53. Flaumenhaft R, Abe M, Sato Y, et al.: Role of the latent TGF-β binding protein in the activation of latent TGF-β by co-cultures of endothelial and smooth muscle cells. J Cell Biol 1993;120:995-1002.
54. Oreffo ROC, Mundy GR, Seyeden SM, Bonewald LF: Activation of the bone derived latent TGF β complex by isolated osteoclasts. Biochem Biophys Res Commun 1989;158:817-823.
55. Massague J: Receptors for the TGF-β family. Cell 1992; 69:1067-1070.
56. Boyd FT, Massague J: Transforming growth factor-β inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. J Biol Chem 1989;264:2272-2278.
57. Wrana JL, Attisano L, Wieser R, Ventura F, Massague J: Mechanism of activation of the TGF-β receptor. Nature (Lond) 1994;370:341-347.